Trials / NCT03349242
Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)
Completed Observational Natural history / observational
- Sponsor
- MeiraGTx UK II Ltd
- Treatment
- Not listed
- Gene
- RPGR
- Conditions
- Retinitis Pigmentosa
- Ages
- 5 Years to no upper limit
- Enrollment
- 140 participants
- Started
- 2017-12-19
- Main results expected
- 2024-04-19
- Results posted
- Not yet
- Record last updated
- 2024-06-20
What the study is testing
The rod-cone dystrophies (often referred to as retinitis pigmentosa (RP)) are a clinically and genetically heterogeneous group of disorders in which there is progressive loss of rod and later cone photoreceptor function leading to severe visual impairment. RP usually occurs as an isolated retinal disorder, but it may also be seen in association with systemic abnormalities.
Where it runs
Canada (1)
- The Hospital for Sick Children, Toronto
United Kingdom (1)
- Moorfields Eye Hospital, London
United States (6)
- Shiley Eye Institute - UCSD, La Jolla, California
- Stanford University, Spencer Center for Vision Research, Stanford, California
- Emory Eye Centre, Atlanta, Georgia
- Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
- Kellogg Eye Center, Ann Arbor, Michigan
- UPMC Eye Centre, Pittsburgh, Pennsylvania